Bio-Rad Laboratories, Inc. v. 10X Genomics Inc., No. 19-2255 (Fed. Cir. Aug. 3, 2020)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Bio-Rad Laboratories, Inc. and the University of Chi- cago (collectively, “Bio- Rad”), accused 10X Genomics Inc. (“10X”) of infringing three patents : U.S. Patent Nos. 8,889,083 ( “’083 patent ”); 8,304,193 ( “’193 patent ”); and 8,329,407 (“’407 patent”). The United States District Court for the District of Delaware held a jury trial in November 2018. The jury found all three patents valid and willfully infringed. It also awarded damages in the amount of $23,930,716.